f Stroke Prioritisation category Outcome Short-listed by Cost, BOD, stakeholder priority Criterion1.1 Serious consequences to the patient Evidence 136 771 – burden DALYs 2011 Criterion 1.1 Serious consequences to the patient Evidence 3.00% – of total DALYs 2011 –% Criterion 1.1 Serious consequences to the patient Score 1 – Criterion 1.3 High cost to health system Evidence NHCDC $0.39 billion – – hospital cost Criterion 1.3 High cost to health system Evidence % of 1.16% – – total cost from NCCH Criterion 1.3 High cost to health system Score 0.5 – Criterion 2.2 Clinician support Evidence Leadership group Established leadership group - Australian Stroke Clinical Registry – – Criterion 2.2 Clinician support Evidence Current clinical Australian Stroke Clinical Registry, Australian Thrombolysis Registry – – quality registries Criterion 2.2 Clinician support Score 1 – Total score 2.5
f Stroke Prioritisation category Outcome Short-listed by Cost, BOD, stakeholder priority Criterion1.1 Serious consequences to the patient – Evidence burden DALYs 2011 136 771 Criterion 1.1 Serious consequences to the patient – Evidence –% of total DALYs 2011 3.00% Criterion 1.1 Serious consequences to the patient – Score 1 Criterion 1.3 High cost to health system – Evidence – NHCDC hospital cost $0.39 billion Criterion 1.3 High cost to health system – Evidence – % of total cost from NCCH 1.16% Criterion 1.3 High cost to health system – Score 0.5 Criterion 2.2 Clinician support – Evidence – Leadership group Established leadership group - Australian Stroke Clinical Registry Criterion 2.2 Clinician support – Evidence – Current clinical quality registries Australian Stroke Clinical Registry, Australian Thrombolysis Registry Criterion 2.2 Clinician support – Score 1 Total score 2.5
Prioritised-list-of-clinical-domains-for-clinical-quality-registry-development-Final-report-Nov-2016.docx